Inactivation of adipose angiotensinogen reduces adipose tissue macrophages and increases metabolic activity

Obesity

Volumn 24, Issue 2, 2016, Pages 359-367

  LeMieux, Monique J ^a   Ramalingam, Latha ^a   Mynatt, Randall L ^b   Kalupahana, Nishan S ^a,c   Kim, Jung Han ^d   Moustaïd Moussa, Naïma ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

^d MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CELL METABOLISM; CONTROLLED STUDY; FAT MASS; FATTY ACID METABOLISM; FLUX ASSAY; GENE EXPRESSION; GENOTYPE; GLUCOSE TRANSPORT; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; LOW FAT DIET; MACROPHAGE; METABOLISM; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROMA CELL; STROMA VASCULAR CELL; WHITE ADIPOSE TISSUE; WILD TYPE MOUSE; ANIMAL;

ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANGIOTENSINOGEN; ANIMALS; INFLAMMATION; MACROPHAGES; MICE; MICE, KNOCKOUT;

EID: 84956583530     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21352     Document Type: Article

References (40)

1. Siriwardhana N, Kalupahana NS, Fletcher S, et al.; n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-kappaB-dependent mechanisms. J Nutr Biochem 2012; 23: 1661-1667.
2. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ.; Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012; 33: 26-34.
3. Gu P, Xu A.; Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 2013; 14: 49-58.
4. Moreno-Aliaga MJ, Lorente-Cebrián S, Martínez JA.; Regulation of adipokine secretion by n-3 fatty acids. Proc Nutr Soc 2010; 69: 324-332.
5. Ouchi N, Parker JL, Lugus JJ, Walsh K.; Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
6. Flachs P, Rossmeisl M, Bryhn M, Kopecky J.; Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci 2009; 116: 1-16.
7. Kalupahana NS, Moustaid-Moussa N.; The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev 2012; 13: 136-149.
8. Engeli S, Negrel R, Sharma AM.; Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270-1277.
9. Kalupahana NS, Moustaid-Moussa N.; The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit Rev Biochem Mol Biol 2012; 47: 379-390.
10. Yvan-Charvet L, Quignard-Boulangé A.; Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 2011; 79: 162-168.
11. Jones BH, Standridge MK, Moustaid N.; Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.
12. Kalupahana NS, Massiera F, Quignard-Boulange A, et al.; Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity 2012; 20: 48-56.
13. Massiera F, Seydoux J, Geloen A, et al.; Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 2001; 142: 5220-5225.
14. Niklason A, Hedner T, Niskanen L, Lanke J.; Group ftCS. Development of diabetes is retarded by ACE inhibition in hypertensive patients-a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens 2004; 22: 645-652.
15. Yusuf S, Gerstein H, Hoogwerf B, et al.; Ramipril and the development of diabetes. JAMA 2001; 286: 1882-1885.
16. Kim S, Urs S, Massiera F, et al.; Effects of high-fat diet, angiotensinogen (agt) gene inactivation, and targeted expression to adipose tissue on lipid metabolism and renal gene expression. Horm Metab Res 2002; 34: 721-725.
17. Kouyama R, Suganami T, Nishida J, et al.; Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 2005; 146: 3481-3489.
18. Takahashi N, Li F, Hua K, et al.; Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 2007; 6: 506-512.
19. Yvan-Charvet L, Even P, Bloch-Faure M, et al.; Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005; 54: 991-999.
20. Yvan-Charvet L, Massiera F, Lamande N, et al.; Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology 2009; 150: 1421-1428.
21. Carroll WX, Kalupahana NS, Booker SL, et al.; Angiotensinogen gene silencing reduces markers of lipid accumulation and inflammation in cultured adipocytes. Front Endocrinol 2013; 4: 10.
22. ImageJ: Image Processing and Analysis in Java. 2014. Available from: http://imagej.nih.gov/ij/. [cited July 2014].
23. Schindelin J, Arganda-Carreras I, Frise E, et al.; Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676-682.
24. Kalupahana NS, Claycombe K, Newman SJ, et al.; Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 2010; 140: 1915-1922.
25. LeMieux MJ, Kalupahana NS, Scoggin S, Moustaid-Moussa N.; Eicosapentaenoic acid induces adipocyte hypotrophy and reduces adipocyte inflammation in an adiposity-independent manner. J Nutr 2015; 145 (3): 411-417.
26. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
27. Yiannikouris F, Karounos M, Charnigo R, et al.; Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol 2012; 302: R244-R251.
28. Yiannikouris F, Gupte M, Putnam K, et al.; Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012; 60: 1524-1530.
29. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R.; Angiotensin II as a trophic factor of white adipose tissue: Stimulation of adipose cell formation. Endocrinology 2001; 142: 487-492.
30. Darimont C, Vassaux G, Ailhaud G, Negrel R.; Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 1994; 135: 2030-2036.
31. Matsuo Y, Gleitsmann K, Mangner N, et al.; Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines. J Cachexia Sarcopenia Muscle 2015; 6: 62-72.
32. Jia JJ, Zhang X, Ge CR, Jois M.; The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes. Obes Rev 2009; 10: 519-526.
33. Saltzman E, Roberts SB.; The role of energy expenditure in energy regulation: findings from a decade of research. Nutr Rev 1995; 53: 209-220.
34. Cottam DR, Mattar SG, Barinas-Mitchell E, et al.; The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
35. Cavallari JF, Fullerton MD, Denou E, et al.; 22: NOD2 immunity protects against obesity-induced inflammation and insulin resistance. Cytokine 2014; 70: 33.
36. Adachi T, Inoue M, Hara H, Maehata E, Suzuki S.; Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 2004; 181: 413-417.
37. Isogawa A, Yamakado M, Yano M, Shiba T.; Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Res Clin Pract 2009; 86: 213-218.
38. de Cavanagh EM, Ferder M, Inserra F, Ferder L.; Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 2009; 296 (3):H550-8. doi: 10.1152/ajpheart.01176.2008. Epub 2009 Jan 16.
39. Manucha W, Ritchie B, Ferder L.; Hypertension and insulin resistance: implications of mitochondrial dysfunction. Curr Hypertens Rep 2014; 17: 1-7.
40. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD.; Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation. 1998; 98: 800-807.